Showing all 69 results
Abacavir & Lamivudine Tablets.
FreeProduct Composition & Strength
We supply this product in the globally standardized “600/300” ratio, optimized for maximum efficacy with a convenient once-daily dosing schedule.
Active Ingredient Strength Primary Clinical Function Abacavir (as Sulfate) USP/BP 600 mg The Guanosine Analogue: Stops viral DNA synthesis by mimicking the guanosine building block. Lamivudine USP/BP 300 mg The Cytidine Analogue: A highly potent NRTI that works synergistically to block the reverse transcriptase enzyme. Excipients Proprietary Matrix Bio-Stable Coating: Engineered to ensure consistent absorption and protect the APIs from environmental degradation. Abacavir Tablets
FreeProduct Composition & Strength
We supply this product in standardized strengths to allow for both adult and pediatric weight-based dosing.
Active Ingredient Strength Primary Clinical Function Abacavir (as Sulfate) USP/BP/Ph.Eur. 300 mg The Standard Dose: Usually taken twice daily as part of a multi-drug regimen. Abacavir (as Sulfate) USP/BP/Ph.Eur. 600 mg The Once-Daily Anchor: Optimized for patient compliance in simplified treatment schedules. Excipients Proprietary Matrix Bio-Stable System: Engineered to ensure consistent oral absorption and protect the API from environmental degradation. Abiraterone acetate Tablets
FreeProduct Composition & Strength
We supply this product in standardized strengths designed for high-dose oncology regimens.
Active Ingredient Strength Primary Clinical Function Abiraterone Acetate USP/Ph.Eur. 250 mg The Standard Unit: Used in a 4-tablet daily regimen to reach the 1000 mg therapeutic dose. Abiraterone Acetate USP/Ph.Eur. 500 mg The High-Compliance Unit: Reduces “pill burden” for elderly patients (2 tablets daily). Excipients Micronized Matrix Enhanced Bioavailability: Engineered to ensure consistent absorption of this lipophilic (fat-soluble) molecule. Acebrophylline (SR) Montelukast & Fexofenadine Tablets
FreeProduct Composition & Strength
We supply this product as a Sustained-Release, Film-Coated Tablet, engineered to provide a steady-state therapeutic concentration over a full 24-hour cycle.
Active Ingredient Strength Primary Clinical Function Acebrophylline (SR) USP/BP 200 mg The Broncho-Mucolytic: Relaxes airways and thins mucus for 24-hour breathing comfort. Montelukast (as Sodium) USP/BP 10 mg The LTRA: Prevents chronic inflammation and asthma triggers in the lungs. Fexofenadine HCl USP/BP 120 mg The Antihistamine: Provides non-sedating relief from upper respiratory allergic symptoms. Acebrophylline & Montelukast TabletsÂ
FreeProduct Composition & Strength
We supply this product as a Sustained-Release, Film-Coated Tablet, engineered to provide synchronized therapeutic levels with convenient once-daily dosing.
Active Ingredient Strength Primary Clinical Function Acebrophylline (SR) USP/BP 200 mg The Airway Opener: Provides 24-hour bronchodilation and thins thick mucus. Montelukast (as Sodium) USP/BP 10 mg The Inflammation Blocker: Prevents asthma triggers and reduces lung swelling. Excipients Hydrophilic Matrix Controlled-Release System: Engineered to provide a smooth plasma curve, minimizing heart palpitations. Acebrophylline Tablets
FreeProduct Composition & Strength
We supply this product as both an Immediate-Release Tablet for acute management and a Sustained-Release (SR) Tablet for 24-hour protection.
Active Ingredient Strength Primary Clinical Function Acebrophylline USP/BP 100 mg The Standard Relief Unit: Taken twice daily to manage active symptoms of bronchitis and asthma. Acebrophylline USP/BP 200 mg SR The 24-Hour Anchor: A sustained-release format that provides consistent airway stability with once-daily dosing. Excipients Hydrophilic Matrix Controlled-Release System: Engineered to provide a smooth plasma concentration curve, minimizing the risk of “Theophylline-like” side effects. Aceclofenac ,Paracetamol & Trypsin-Chymotrypsin 150000AU Tablets
FreeProduct Composition & Strength
We supply this product as a Film-Coated, Enteric-Shielded Tablet to ensure the enzymes are protected from stomach acid and absorbed in the intestine.
Active Ingredient Strength Primary Clinical Function Aceclofenac USP/BP 100 mg The Anti-Inflammatory: Reduces joint pain and physical swelling of the tissues. Paracetamol USP/BP 325 mg The Analgesic: Provides rapid relief from acute pain and manages fever. Trypsin-Chymotrypsin 150,000 AU The Enzyme Payload: Resolves inflammation and clears edema to accelerate tissue repair. Aceclofenac , Paracetamol and Serratiopeptidase Tablets
FreeProduct Composition & Strength
We supply this product as a Film-Coated, Enteric-Shielded Tablet to ensure the enzyme remains active through the stomach acid.
Active Ingredient Strength Primary Clinical Function Aceclofenac USP/BP 100 mg The Anti-Inflammatory: Reduces joint and tissue inflammation and stiffness. Paracetamol USP/BP 325 mg The Analgesic: Provides rapid relief from acute pain and manages fever. Serratiopeptidase 15 mg The Enzyme Payload: Resolves inflammation and clears edema to accelerate tissue repair. Aceclofenac , Paracetamol and Tizanidine Tablets
FreeProduct Composition & Strength
We supply this product as a Film-Coated Tablet, engineered for synchronized absorption to ensure the muscle relaxant and pain reliever reach therapeutic levels at the same time.
Active Ingredient Strength Primary Clinical Function Aceclofenac USP/BP 100 mg The Anti-Inflammatory: Reduces joint and tissue inflammation and stiffness. Paracetamol USP/BP 325 mg The Analgesic: Provides rapid relief from acute pain and manages fever. Tizanidine (as HCl) USP/BP 2 mg The Muscle Relaxant: Relieves painful muscle spasms and improves physical mobility. Aceclofenac & Paracetamol TabletsÂ
FreeProduct Composition & Strength
We supply this product as a Film-Coated Tablet, engineered for rapid disintegration and synchronized absorption.
Active Ingredient Strength Primary Clinical Function Aceclofenac USP/BP 100 mg The Anti-Inflammatory: Targets tissue inflammation and reduces joint stiffness. Paracetamol USP/BP 325 mg / 500 mg The Analgesic: Provides rapid relief from acute pain and manages fever. Excipients Proprietary Matrix Rapid-Release System: Engineered to ensure both APIs reach therapeutic levels within 30–60 minutes. Aceclofenac, Paracetamol & Chlorzoxazone Tablets
FreeProduct Composition & Strength
We supply this product as a Film-Coated Tablet, engineered for synchronized absorption to ensure the muscle relaxant and pain reliever reach therapeutic levels at the same time.
Active Ingredient Strength Primary Clinical Function Aceclofenac USP/BP 100 mg The Anti-Inflammatory: Reduces joint and tissue inflammation and stiffness. Paracetamol USP/BP 325 mg The Analgesic: Provides rapid relief from acute pain and manages fever. Chlorzoxazone USP/BP 250 mg / 500 mg The Muscle Relaxant: Relieves painful muscle spasms and improves physical mobility. Acenocoumarol Tablets
FreeProduct Composition & Strength
We supply this product in multiple strengths to allow for the precise, micro-gram level titration required for safe anticoagulation.
Active Ingredient Strength Primary Clinical Function Acenocoumarol USP/BP/Ph.Eur. 1 mg / 2 mg The Titration Unit: Used for fine-tuning the maintenance dose to keep the INR within the target range (usually 2.0–3.0). Acenocoumarol USP/BP/Ph.Eur. 3 mg / 4 mg The Loading/Anchor Dose: Used for initial therapy or for patients requiring higher systemic anticoagulation. Excipients Proprietary Matrix Bio-Stable System: Engineered to ensure consistent oral absorption and predictable pharmacokinetics. Acetaminophen & Tramadol Hydrochloride Tablets
FreeProduct Composition & Strength
We supply this product in the globally standardized “325/37.5” ratio, optimized for maximum efficacy with minimal opioid-related side effects.
Active Ingredient Strength Primary Clinical Function Acetaminophen (Paracetamol) USP/BP 325 mg The Rapid Starter: Provides quick onset of analgesia and antipyretic (fever-reducing) effects. Tramadol Hydrochloride USP/BP 37.5 mg The Sustained Blocker: Provides moderate-to-severe pain relief via opioid and neurotransmitter pathways. Excipients Proprietary Matrix Bio-Synchronized System: Engineered to ensure both APIs reach therapeutic plasma levels simultaneously for a synergistic effect. Acetyl Salicylic Acid Tablets
FreeProduct Composition & Strength
We supply this product in two distinct clinical ranges: the “Cardio-Shield” range and the “Analgesic-Power” range.
Active Ingredient Strength Primary Clinical Function Acetylsalicylic Acid USP/BP 75 mg / 100 mg The Cardio-Shield: Once-daily “Baby Aspirin” for long-term prevention of heart attack and stroke. Acetylsalicylic Acid USP/BP 300 mg The Emergency Loading Dose: Used immediately during a suspected heart attack to break up clots. Acetylsalicylic Acid USP/BP 500 mg The Analgesic Anchor: For the relief of headache, toothache, and musculoskeletal pain. Aciclovir Tablets
FreeProduct Composition & Strength
We supply this product in standardized strengths to cover everything from simple cold sores to severe shingles cases.
Active Ingredient Strength Primary Clinical Function Aciclovir USP/BP/Ph.Eur. 200 mg The Herpes Unit: Standard dose for the treatment and suppression of Herpes Simplex (HSV-1 and HSV-2). Aciclovir USP/BP/Ph.Eur. 400 mg The Prophylactic Anchor: Used for long-term suppression in immunocompromised patients. Aciclovir USP/BP/Ph.Eur. 800 mg The Zoster Payload: High-potency dose required to treat Shingles (Herpes Zoster) and Chickenpox. Acitretin Tablets
FreeProduct Composition & Strength
We supply this product in standardized strengths to allow for precise clinical titration, packed in high-barrier Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Acitretin USP/Ph.Eur. 10 mg The Titration Unit: Used to start therapy or for maintenance in patients sensitive to retinoids. Acitretin USP/Ph.Eur. 25 mg The Therapeutic Anchor: The standard dose for achieving rapid clearance of severe skin lesions. Excipients Proprietary Matrix Bio-Stable System: Engineered to ensure consistent oral absorption (approx. 60% bioavailability when taken with food). Activated Charcoal Tablets
FreeProduct Composition & Strength
We supply this product as a High-Density, Compressible Tablet, engineered to disintegrate rapidly in the stomach for maximum surface area exposure.
Active Ingredient Strength Primary Clinical Function Activated Charcoal USP/BP/Ph.Eur. 250 mg The GI Relief Unit: Used primarily for over-the-counter (OTC) management of gas and bloating. Activated Charcoal USP/BP/Ph.Eur. 500 mg The Emergency Payload: High-potency format for clinical detoxification and poisoning management. Excipients Binder/Disintegrant Rapid-Discharge Matrix: Engineered to ensure the charcoal particles disperse immediately upon contact with gastric fluid. Afatinib Tablets
FreeProduct Composition & Strength
We supply this product in multiple strengths to allow for precise dose titration based on patient tolerability.
Active Ingredient Strength Primary Clinical Function Afatinib (as Dimaleate) USP/Ph.Eur. 20 mg / 30 mg The Dose-Adjustment Unit: Used for patients requiring a lower dose due to gastrointestinal or skin toxicity. Afatinib (as Dimaleate) USP/Ph.Eur. 40 mg The Standard Therapeutic Anchor: The globally validated starting dose for first-line treatment of EGFR+ NSCLC. Excipients Proprietary Matrix Bio-Stable Coating: Engineered to protect the sensitive dimaleate salt and ensure consistent systemic absorption. Agomelatine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Bioavailability Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the API.
Active Ingredient Strength Primary Clinical Function Agomelatine USP/Ph.Eur. 25 mg The Therapeutic Anchor: The globally validated dose for restoring circadian rhythm and treating major depression. Excipients Proprietary Matrix Bio-Synchronized Release: Engineered to ensure a rapid $T_{max}$ (approx. 1-2 hours) to align with the body’s natural melatonin surge. Alfuzosin & Dutasteride Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Bi-Layer or Capsule-in-Tablet format, packed in high-barrier Alu-Alu blister strips to ensure the stability of the moisture-sensitive Dutasteride.
Active Ingredient Strength Primary Clinical Function Alfuzosin HCl (Extended-Release) USP/BP 10 mg The Rapid Reliever: Provides immediate improvement in urine flow by relaxing prostate muscles. Dutasteride USP/BP 0.5 mg The Long-Term Shaper: Reduces the physical size of the prostate to prevent the need for surgery. Excipients Hydrophilic Matrix Controlled-Release System: Engineered to provide synchronized 24-hour therapeutic coverage with once-daily dosing. Alfuzosin Hydrochloride TabletsÂ
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Extended-Release (ER) Tablet, packed in high-barrier Alu-Alu blister strips to ensure API stability.
Active Ingredient Strength Primary Clinical Function Alfuzosin Hydrochloride USP/BP 10 mg The Standard Therapeutic Anchor: The globally validated once-daily dose for moderate-to-severe BPH symptoms. Excipients Extended-Release Matrix Controlled-Delivery System: Engineered to provide synchronized 24-hour therapeutic coverage, eliminating the need for multiple daily doses. Allylestrenol Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Bio-Stable Tablet, packed in high-barrier Alu-Alu blister strips to ensure hormonal stability.
Active Ingredient Strength Primary Clinical Function Allylestrenol USP/BP/Ph.Eur. 5 mg The Standard OB-GYN Anchor: The globally validated dose for maintaining the corpus luteum and supporting the early placenta. Excipients Proprietary Matrix Bio-Synchronized System: Engineered to ensure rapid oral absorption and high plasma concentration to provide immediate uterine stability. Alpelisib Tablets
FreeProduct Composition & Strength
We supply this product in standardized daily dose packs, designed to achieve the 300 mg daily therapeutic target.
Active Ingredient Strength Primary Clinical Function Alpelisib USP/Ph.Eur. 50 mg / 150 mg The Combination Unit: Used together (150mg x 2) to reach the standard 300mg daily dose. Alpelisib USP/Ph.Eur. 200 mg The Dose-Reduction Unit: Used for patients requiring a lower dose due to side effects (Hyperglycemia/Rash). Excipients Proprietary Matrix Bio-Stable Coating: Engineered to protect the sensitive API and ensure consistent systemic absorption. Alpha Ketoanalogue Tablets
FreeProduct Composition & Strength
We supply this product as a Multi-Mineral, Amino Acid Complex, carefully balanced to meet the Nutritional Requirements of Uremic Patients.
Component (Active) Amount per Tablet Clinical Function Alpha-Keto-Isoleucine / Leucine / Valine / Phenylalanine Calcium Salts The Protein Builders: Converted into essential amino acids using waste nitrogen. Alpha-Hydroxy-Methionine Calcium Salt The Sulfur Source: Provides the essential hydroxy-analog of methionine. L-Lysine / L-Threonine / L-Tryptophan Acetate/Pure Form Essential Amino Acids: Direct supplementation of AA that the body cannot synthesize. L-Histidine / L-Tyrosine Pure Form Conditional Amino Acids: Critical for maintaining nitrogen balance in renal failure. Calcium Content ~50 mg (approx) Phosphate Binder Support: Provides calcium which helps in managing hyperphosphatemia. Alprazolam & Sertraline Hydrochloride Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Film-Coated Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the benzodiazepine component.
Active Ingredient Strength Primary Clinical Function Sertraline (as HCl) USP/BP 25 mg / 50 mg The Antidepressant Anchor: Provides long-term correction of serotonin levels to treat depression and OCD. Alprazolam USP/BP 0.25 mg / 0.5 mg The Anxiolytic Bridge: Provides rapid relief from acute anxiety and prevents panic spikes. Excipients Proprietary Matrix Bio-Synchronized System: Engineered to ensure the rapid release of Alprazolam for immediate relief while Sertraline maintains steady-state plasma levels. Alprostadil Tablets
FreeProduct Composition & Strength
We supply this product in high-purity oral and specialized dispersible formats, primarily for hospital and specialist use.
Active Ingredient Strength Primary Clinical Function Alprostadil USP/BP/Ph.Eur. 0.5 mg The Neonatal Unit: Used in controlled hospital settings for maintaining ductal patency in infants with congenital heart defects. Alprostadil USP/BP/Ph.Eur. 1 mg The Vascular/Urology Anchor: Used for severe peripheral vascular disease or refractory erectile dysfunction. Excipients Proprietary Matrix Bio-Stable System: Engineered to prevent the rapid degradation of the sensitive prostaglandin molecule during transit. Amantadine Hydrochloride TabletsÂ
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Immediate-Release Tablet, packed in moisture-resistant Alu-Alu or Alu-PVC blister strips.
Active Ingredient Strength Primary Clinical Function Amantadine Hydrochloride USP/BP 100 mg The Standard Therapeutic Anchor: The globally validated dose for both Parkinsonian motor control and antiviral prophylaxis. Excipients Proprietary Matrix Rapid-Release System: Engineered to ensure a consistent $T_{max}$ (peak concentration) of approx. 2 to 4 hours for reliable daily protection. Ambrisentan Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Potency Tablet, packed in high-barrier Alu-Alu blister strips to ensure API stability.
Active Ingredient Strength Primary Clinical Function Ambrisentan USP/Ph.Eur. 5 mg The Initiation Unit: The standard starting dose for adults to establish tolerance and initial pulmonary dilation. Ambrisentan USP/Ph.Eur. 10 mg The Maximum Maintenance Payload: For patients requiring additional symptomatic improvement after the 5 mg dose. Excipients Proprietary Matrix Bio-Optimized System: Engineered to ensure a consistent $T_{max}$ (peak concentration) of approx. 2 hours for reliable daily protection. Amiloride & Hydrochlorothiazide TabletsÂ
FreeProduct Composition & Strength
We supply this product in the globally standardized strength ratio, packed in high-barrier Alu-PVC or Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Amiloride (as HCl) USP/BP 5 mg The Potassium Guard: Prevents the loss of potassium, protecting against heart arrhythmias and muscle weakness. Hydrochlorothiazide USP/BP 50 mg The Volume Reducer: Excretes excess sodium and water to reduce the load on the heart and vessels. Excipients Proprietary Matrix Steady-State Release System: Engineered to ensure a consistent diuretic effect over a full 24-hour cycle. Aminosalicylic Acid Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Delayed-Release (DR) Tablet, packed in moisture-resistant Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function 4-Aminosalicylic Acid USP/BP 500 mg The Standard Titration Unit: Allows for gradual dose escalation to manage gastrointestinal side effects. 4-Aminosalicylic Acid USP/BP 1000 mg The Maintenance Payload: High-dose format for adult MDR-TB regimens requiring up to 8–12g daily. Excipients Acid-Resistant Polymer Enteric Shield System: Engineered to bypass the stomach and release the API in the upper intestine for maximum absorption. Amisulpride Tablets
FreeProduct Composition & Strength
We supply this product in a full range of strengths to facilitate both low-dose “Disthymia” protocols and high-dose “Schizophrenia” maintenance.
Active Ingredient Strength Primary Clinical Function Amisulpride USP/BP 50 mg / 100 mg The Negative Symptom Unit: Used to treat social withdrawal, depression, and lack of initiative. Amisulpride USP/BP 200 mg The Transition Anchor: Used for moderate psychosis or as a step-up dose during titration. Amisulpride USP/BP 400 mg The Positive Symptom Payload: High-potency dose for acute psychotic episodes and hallucinations. Amitriptyline & Chlordiazepoxide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Film-Coated Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the benzodiazepine component.
Active Ingredient Strength Primary Clinical Function Amitriptyline (as HCl) USP/BP 12.5 mg / 25 mg The Antidepressant Anchor: Elevates mood and energy levels by modulating neurotransmitter reuptake. Chlordiazepoxide USP/BP 5 mg / 10 mg The Anxiolytic Shield: Provides rapid relief from nervousness, agitation, and muscle tension. Excipients Proprietary Matrix Bio-Synchronized System: Engineered to ensure the rapid onset of the anxiolytic effect while the antidepressant effect builds over time. Amlodipine & Hydrochlorothiazide TabletsÂ
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Film-Coated Tablet, engineered for synchronized 24-hour hemodynamic control.
Active Ingredient Strength Primary Clinical Function Amlodipine (as Besylate) USP/BP 5 mg / 10 mg The Vasodilator: Reduces the resistance of blood vessels to lower systemic pressure. Hydrochlorothiazide USP/BP 12.5 mg / 25 mg The Volume Reducer: Excretes excess sodium and water to reduce circulatory load. Excipients Proprietary Matrix Steady-State System: Engineered to ensure consistent plasma concentrations of both drugs to prevent “dips” in BP control. Amoxapine Tablets
FreeProduct Composition & Strength
We supply this product in a full range of strengths to allow for precise clinical titration, packed in high-barrier Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Amoxapine USP/BP 25 mg / 50 mg The Titration Unit: Used for gradual dose escalation to minimize initial sedative effects. Amoxapine USP/BP 100 mg The Standard Anchor: The primary maintenance dose for outpatients with moderate depression. Amoxapine USP/BP 150 mg The High-Potency Payload: For hospitalized patients with severe psychotic or endogenous depression. Amoxicillin & Potassium Clavulanate Dispersible Tablets
FreeProduct Composition & Strength
We supply this product in the globally standardized 7:1 ratio, packed in high-barrier Alu-Alu blister strips to ensure the stability of the moisture-sensitive Clavulanate.
Active Ingredient Strength Primary Clinical Function Amoxicillin (as Trihydrate) USP/BP 200 mg / 400 mg The Growth Inhibitor: Destroys the bacterial cell wall across a broad range of pathogens. Potassium Clavulanate USP/BP 28.5 mg / 57 mg The Resistance Shield: Neutralizes bacterial enzymes, allowing Amoxicillin to function. Excipients Sweetened Matrix Pediatric-Friendly System: Engineered with pleasant fruit flavors to ensure 100% child compliance. Amoxicillin Trihydrate Dispersible Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Fruit-Flavored Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the moisture-sensitive API.
Active Ingredient Strength Primary Clinical Function Amoxicillin (as Trihydrate) USP/BP 125 mg The Pediatric Starter: Ideal for infants and toddlers requiring low-dose respiratory or ear infection therapy. Amoxicillin (as Trihydrate) USP/BP 250 mg The Junior Anchor: The standard dose for older children and adolescents for broad-spectrum anti-infective coverage. Excipients Sweetened Matrix Taste-Masking System: Engineered with pleasant flavors (Strawberry/Pineapple/Orange) to overcome the natural bitterness of the antibiotic. Amoxycillin , Cloxacillin And Lactic Acid Bacillus Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Film-Coated Tablet or Capsule, packed in high-barrier Alu-Alu blister strips to ensure the stability of the live probiotic spores.
Active Ingredient Strength Primary Clinical Function Amoxycillin (as Trihydrate) USP/BP 250 mg The Growth Inhibitor: Destroys the bacterial cell wall across a broad range of pathogens. Cloxacillin (as Sodium) USP/BP 250 mg The Defense Breaker: Specifically neutralizes bacterial enzymes, making the treatment effective against “Staph” infections. Lactic Acid Bacillus (LAB) 1.5 Billion Spores The Biological Shield: Replenishes healthy gut bacteria to prevent diarrhea and boost immunity. Amoxycillin Dispersible Kid Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Fruit-Flavored Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the moisture-sensitive API.
Active Ingredient Strength Primary Clinical Function Amoxycillin (as Trihydrate) USP/BP 125 mg The Pediatric Starter: Ideal for infants and toddlers requiring low-dose respiratory or ear infection therapy. Amoxycillin (as Trihydrate) USP/BP 250 mg The Junior Anchor: The standard dose for older children and adolescents for broad-spectrum anti-infective coverage. Excipients Sweetened Matrix Taste-Masking System: Engineered with pleasant flavors (Strawberry/Pineapple/Orange) to overcome the natural bitterness of the antibiotic. Anastrozole Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Cytotoxic Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the active API.
Active Ingredient Strength Primary Clinical Function Anastrozole USP/Ph.Eur. 1 mg The Standard Oncology Anchor: The globally validated dose for both adjuvant and first-line treatment of advanced breast cancer. Excipients Proprietary Matrix High-Containment Coating: Engineered with an impenetrable film-coat to prevent the release of cytotoxic dust, ensuring safety for healthcare workers. Apixaban Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Bioavailability Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the active API.
Active Ingredient Strength Primary Clinical Function Apixaban USP/Ph.Eur. 2.5 mg The Dose-Reduction Unit: Used for patients with specific risk factors (Age ≥80, Weight ≤60kg, or high Creatinine) to minimize bleeding. Apixaban USP/Ph.Eur. 5 mg The Therapeutic Anchor: The standard maintenance dose for stroke prevention in Atrial Fibrillation and DVT treatment. Excipients Proprietary Matrix Rapid-Dissolution System: Engineered to ensure a consistent $T_{max}$ of approx. 3 to 4 hours for reliable protection. Apremilast tablets
FreeProduct Composition & Strength
We supply this product in a standardized titration pack format or individual strengths to ensure patient safety during the initial phase.
Active Ingredient Strength Primary Clinical Function Apremilast USP/Ph.Eur. 10 mg / 20 mg The Titration Unit: Used during the first 5 days of therapy to minimize gastrointestinal side effects. Apremilast USP/Ph.Eur. 30 mg The Therapeutic Anchor: The standard maintenance dose for long-term control of Psoriasis and Psoriatic Arthritis. Excipients Proprietary Matrix Bio-Synchronized Release: Engineered to ensure a consistent $T_{max}$ of approx. 2.5 hours for steady-state immune modulation. Aripipralzole Tablets
FreeProduct Composition & Strength
We supply this product in a wide range of strengths to allow for precise clinical titration, packed in moisture-resistant Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Aripiprazole USP/Ph.Eur. 2 mg / 5 mg The Titration/Adjunct Unit: Used for initial dosing or as an add-on for Major Depressive Disorder. Aripiprazole USP/Ph.Eur. 10 mg / 15 mg The Standard Anchor: The primary maintenance dose for Schizophrenia and Bipolar Disorder. Aripiprazole USP/Ph.Eur. 20 mg / 30 mg The High-Potency Payload: For acute manic episodes or treatment-resistant cases under specialist care Aspirin Tablets
FreeProduct Composition & Strength
We supply this product in various formats, including Gastro-resistant (Enteric-coated), Dispersible, and standard Film-coated tablets.
Active Ingredient Strength Primary Clinical Function Aspirin (Acetylsalicylic Acid) 75 mg / 81 mg The Cardiac Shield: Low-dose daily therapy for the prevention of heart attack and stroke. Aspirin (Acetylsalicylic Acid) 150 mg Post-Surgical Maintenance: Used for patients with stents or high-risk vascular profiles. Aspirin (Acetylsalicylic Acid) 300 mg / 500 mg The Analgesic Anchor: High-dose relief for acute pain, migraine, and rheumatic fever. Atazanavir & Ritonavir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Film-Coated Tablet, engineered for synchronized 24-hour viral suppression.
Active Ingredient Strength Primary Clinical Function Atazanavir (as Sulfate) USP/BP 300 mg The Antiviral Anchor: Blocks the maturation of HIV, preventing the spread of infection to CD4 cells. Ritonavir USP/BP 100 mg The Pharmacokinetic Booster: Inhibits liver metabolism to maintain high Atazanavir levels for 24 hours. Excipients Proprietary Matrix Bio-Enhancement System: Engineered to ensure maximum intestinal absorption, which is critical for PI-class medications. Atenolol & Indapamide TabletsÂ
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Film-Coated Tablet, engineered for synchronized 24-hour hemodynamic control.
Active Ingredient Strength Primary Clinical Function Atenolol USP/BP 50 mg The Heart Rate Regulator: Controls cardiac output and myocardial oxygen demand. Indapamide USP/BP 2.5 mg The Metabolic-Neutral Diuretic: Reduces blood volume and provides direct vascular relaxation. Excipients Proprietary Matrix Steady-State Release System: Engineered to ensure consistent plasma concentrations of both drugs to prevent “dips” in BP control. Atenolol & S-Amlodipine Besylate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Film-Coated Tablet, utilizing high-purity S-Amlodipine Besylate to ensure stability.
Active Ingredient Strength Primary Clinical Function Atenolol USP/BP 25 mg / 50 mg The Heart Rate Regulator: Controls the “Pump” by reducing heart rate and myocardial oxygen demand. S-Amlodipine (as Besylate) USP/BP 2.5 mg / 5 mg The Vessel Relaxant: Pure chiral isomer for maximum vasodilation with minimum side effects (edema). Excipients Proprietary Matrix Chiral-Stability System: Engineered to ensure the S-enantiomer remains stable and does not racemize during the shelf-life. Atorvastatin & Aspirin and Clopidogrel Tablets
FreeProduct Composition & Strength
We supply this product typically in a Capsule-in-Capsule or Multi-Particulate Tablet format to ensure the chemical stability of the three distinct APIs.
Active Ingredient Strength Primary Clinical Function Atorvastatin (as Calcium) USP 10 mg / 20 mg The Lipid Stabilizer: Lowers cholesterol and prevents the growth of arterial blockages. Aspirin (Gastro-resistant) BP 75 mg / 150 mg The Primary Blood Thinner: Prevents initial platelet activation via the COX pathway. Clopidogrel (as Bisulphate) USP 75 mg The Secondary Blood Thinner: Provides high-level protection against stent thrombosis and recurrent stroke. Atorvastatin & Asprin Tablets
FreeProduct Composition & Strength
We supply this product as a Bi-Layered or Film-Coated Tablet, often utilizing specialized enteric coating for the Aspirin component to protect the stomach lining.
Active Ingredient Strength Primary Clinical Function Atorvastatin Calcium USP/BP 10 mg / 20 mg The Lipid Regulator: Controls cholesterol synthesis in the liver and stabilizes arterial walls. Aspirin (Gastro-resistant) BP 75 mg / 150 mg The Anti-Platelet Anchor: Provides low-dose blood thinning to prevent clot formation. Excipients Proprietary Matrix Gastro-Protective System: Engineered to ensure Aspirin dissolves only in the small intestine, minimizing gastric irritation. Azilsartan Medoxomil Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Bioavailability Tablet, packed in moisture-resistant Alu-Alu blister strips to ensure the stability of the Medoxomil ester.
Active Ingredient Strength Primary Clinical Function Azilsartan Medoxomil Potassium 40 mg The Standard Initiation Unit: The primary starting dose for most adult patients with hypertension. Azilsartan Medoxomil Potassium 80 mg The High-Potency Payload: For patients requiring additional blood pressure lowering beyond the 40 mg dose. Excipients Proprietary Matrix Hydrolysis-Stable System: Engineered to prevent premature breakdown of the prodrug before it reaches the gastrointestinal tract. Azithromycin & Cefixime tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Film-Coated Tablet, packed in high-barrier Alu-Alu blister strips to prevent the degradation of the moisture-sensitive API.
Active Ingredient Strength Primary Clinical Function Cefixime (as Trihydrate) USP/BP 200 mg The Gram-Negative Specialist: Targets the cell walls of stubborn bacteria, highly effective in Typhoid and Bronchitis. Azithromycin (as Dihydrate) USP/BP 250 mg / 500 mg The Tissue-Penetrating Anchor: Provides prolonged activity in the lungs and soft tissues to eliminate intracellular pathogens. Excipients Proprietary Matrix Dual-Release System: Engineered to ensure synchronized absorption of both antibiotics despite their different chemical solubilities. Baclofen Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Disintegration Tablet, packed in moisture-resistant Alu-PVC or Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Baclofen USP/BP/Ph.Eur. 10 mg The Standard Titration Unit: The primary dose used for gradual escalation to determine patient tolerance and efficacy. Baclofen USP/BP/Ph.Eur. 20 mg The Maintenance Payload: High-potency dose for patients with severe spasticity from chronic spinal cord injuries. Excipients Proprietary Matrix Rapid-Release System: Engineered to ensure a predictable $T_{max}$ (time to peak concentration) of 1 to 2 hours for fast relief. Baricitinib Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Bioavailability Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the active API.
Active Ingredient Strength Primary Clinical Function Baricitinib USP/Ph.Eur. 2 mg The Standard RA Anchor: The primary maintenance dose for adult patients with moderate-to-severe Rheumatoid Arthritis. Baricitinib USP/Ph.Eur. 4 mg The Dermatology/Severe Payload: High-potency dose utilized for Alopecia Areata and severe Atopic Dermatitis protocols. Excipients Proprietary Matrix Bio-Synchronized System: Engineered to ensure a consistent pharmacokinetic profile (Tmax of approx. 1 hour) for predictable immune suppression. Benfotiamine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Bioavailability Tablet, packed in high-barrier Alu-Alu or Alu-PVC blister strips.
Active Ingredient Strength Primary Clinical Function Benfotiamine USP/Ph.Eur. 100 mg / 150 mg The Neuropathy Anchor: Standard daily dose for the prevention of diabetic complications and nerve maintenance. Benfotiamine USP/Ph.Eur. 300 mg The Therapeutic Max-Payload: High-potency dose for clinical management of established Peripheral Neuropathy and Retinopathy. Excipients Proprietary Matrix Lipid-Enhanced System: Engineered to ensure maximum intestinal uptake and stable plasma concentrations. Benzthiazide & Triamterene Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Disintegration Tablet, packed in high-barrier Alu-PVC or Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Benzthiazide USP/BP 25 mg The Thiazide Payload: The primary driver for sodium and water excretion to lower blood pressure. Triamterene USP/BP 50 mg The Potassium Guardian: Physically prevents the loss of Potassium (K+) during the diuretic process. Excipients Proprietary Matrix Bio-Balance System: Engineered to ensure synchronized dissolution of both active APIs for maximum clinical synergy. Betahistine TabletsÂ
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Disintegration Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the active dihydrochloride salt.
Active Ingredient Strength Primary Clinical Function Betahistine Dihydrochloride USP/Ph.Eur. 8 mg / 16 mg The Standard Maintenance Anchor: Ideal for long-term management of vertigo and tinnitus. Betahistine Dihydrochloride USP/Ph.Eur. 24 mg / 48 mg The Therapeutic Payload: High-potency dose for acute phases of Meniere’s Disease and severe vestibular dysfunction. Excipients Proprietary Matrix Gastric-Gentle System: Engineered to ensure rapid absorption while minimizing the common “histamine-like” gastric irritation. Betamethasone Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Soluble Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the moisture-sensitive sodium phosphate salt.
Active Ingredient Strength Primary Clinical Function Betamethasone Sodium Phosphate BP/USP 0.5 mg The Maintenance Anchor: Standard dose for chronic inflammatory conditions and pediatric allergy management. Betamethasone Sodium Phosphate BP/USP 1 mg (Forte) The Crisis Payload: High-potency therapeutic dose for acute asthma, severe eczema, and drug reactions. Excipients Proprietary Matrix Instant-Dispersible System: Engineered to dissolve in seconds, ensuring maximum bioavailability and ease of administration. Bethanecol Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Bioavailability Tablet, packed in secure Alu-PVC or Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Bethanechol Chloride USP/BP 10 mg The Pediatric & Titration Unit: Ideal for initial dosing or mild cases of gastric atony. Bethanechol Chloride USP/BP 25 mg The Urology Anchor: The standardized therapeutic dose for managing post-operative urinary retention. Excipients Proprietary Matrix Acid-Stable Formulation: Engineered to survive the gastric environment for consistent intestinal absorption. Betnesol forte 1mg Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Soluble Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the moisture-sensitive sodium phosphate salt.
Active Ingredient Strength Primary Clinical Function Betamethasone Sodium Phosphate BP/USP 1 mg The Crisis Anchor: High-potency therapeutic dose for short-term management of acute asthma, severe eczema, and drug reactions. Excipients Proprietary Matrix Instant-Dispersible System: Engineered to dissolve in seconds, ensuring maximum bioavailability and ease of administration for all age groups Bicalutamide Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Cytotoxic Tablet, packed in high-barrier Alu-Alu blister strips to ensure the stability of the active API.
Active Ingredient Strength Primary Clinical Function Bicalutamide USP/Ph.Eur. 50 mg The Metastatic Anchor: Used in combination with a LHRH analogue (medical castration) for advanced metastatic disease. Bicalutamide USP/Ph.Eur. 150 mg The Monotherapy Payload: Utilized as a standalone treatment for locally advanced, non-metastatic prostate cancer. Excipients Proprietary Matrix High-Containment Coating: Engineered with an impenetrable film-coat to prevent the release of cytotoxic dust during handling by healthcare professionals. Bosentan Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Bioavailability Tablet, packed in moisture-resistant Alu-Alu blister strips to ensure the stability of the active API.
Active Ingredient Strength Primary Clinical Function Bosentan (as Monohydrate) USP/Ph.Eur. 62.5 mg The Initiation Unit: Utilized for the first 4 weeks of therapy to assess patient tolerance and liver response. Bosentan (as Monohydrate) USP/Ph.Eur. 125 mg The Maintenance Payload: The standardized therapeutic dose for long-term management of PAH and exercise capacity improvement. Excipients Proprietary Matrix Controlled Disintegration System: Engineered to ensure a predictable pharmacokinetic profile, matching the innovator brand’s $T_{max}$ (time to peak concentration). Bromhexine Hydrochloride Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Disintegration Tablet, packed in moisture-resistant Alu-PVC or Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Bromhexine Hydrochloride BP/USP 8 mg The Respiratory Anchor: The standardized therapeutic unit for adults and children over 12 for the treatment of productive cough. Excipients Proprietary Matrix Rapid Dissolution System: Engineered to ensure the tablet shatters instantly in the stomach for rapid systemic absorption and lung-tissue penetration. Buclizine TabletsÂ
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Fast-Acting Tablet, packed in high-barrier Alu-PVC or Alu-Alu blister strips.
Active Ingredient Strength Primary Clinical Function Buclizine Hydrochloride BP/USP 25 mg The Universal Anchor: The standardized therapeutic unit for both appetite stimulation (adults/pediatrics) and motion sickness prevention. Excipients Proprietary Matrix High-Disintegration System: Engineered to ensure the tablet dissolves rapidly in the gastric environment for a fast onset of action (typically within 30–60 minutes). Calcium Acetate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Disintegration Tablet, packed in moisture-resistant Alu-Alu or HDPE bottles.
Active Ingredient Strength Primary Clinical Function Calcium Acetate USP/Ph.Eur. 667 mg The Dialysis Anchor: Each 667mg tablet provides 169mg of elemental calcium, the standardized dose for maximum phosphate binding. Excipients Proprietary Matrix Rapid Dissolution System: Engineered to ensure the tablet shatters instantly in the stomach to maximize contact with dietary phosphorus during a meal. Dried Aluminium Hydroxide, Magnesium Hydroxide & Simethicone Tablets
FreeProduct Composition & Strength
We supply this product as Chewable Tablets, which is the optimal delivery format to ensure the active ingredients are finely dispersed before reaching the stomach.
Active Ingredient Strength Primary Clinical Function Dried Aluminium Hydroxide Gel 250 mg / 300 mg The Sustained Buffer: Provides long-lasting acid neutralization and forms a protective coating on the stomach lining. Magnesium Hydroxide 250 mg The Rapid Neutralizer: Provides immediate relief from heartburn and balances the digestive transit time. Simethicone 25 mg / 50 mg The Defoaming Agent: Physically breaks down gas bubbles to relieve bloating and abdominal discomfort. Flavors Mint / Fruit / Orange Palatability Matrix: Engineered to be pleasant-tasting to ensure high patient compliance for OTC use. Glimepiride & Metformin Hydrochloride Tablets
FreeProduct Composition & Strength
We supply this product as Bilayered Tablets or Film Coated Tablets. The bilayered technology is often used to manage the different release profiles and physical characteristics of the two APIs.
Active Ingredient Strength (Standard) Therapeutic Role Glimepiride USP/BP/IP 1 mg / 2 mg Sulfonylurea (Insulin Secretagogue) Metformin HCl USP/BP/IP 500 mg / 1000 mg Biguanide (Insulin Sensitizer) Excipients Q.S. Povidone / Magnesium Stearate Stabilizing Core Matrix Glimepiride, Pioglitazone & Metformin Hydrochloride Tablets
FreeProduct Composition & Standard Strengths
We supply this product in standardized Fixed-Dose Combinations (FDCs) designed for flexible clinical titration.
Active Ingredient Common Strength Primary Clinical Function Metformin HCl (SR/IR) 500 mg / 1000 mg The Foundation: Reduces glucose production. Glimepiride 1 mg / 2 mg The Stimulator: Enhances insulin secretion. Pioglitazone 15 mg The Sensitizer: Fixes insulin resistance. Methimazole Tablets
FreeTechnical & Logistics Specifications
HS Code: 3004.90.39 (Medicaments containing hormones or other products – Antithyroid)
CAS Number: 60-56-0 (Methimazole / Thiamazole)
Dosage Form: Uncoated or Film-Coated Tablet
Packaging: Alu-Alu or Alu-PVC Blisters. Protects the sensitive API from environmental humidity; our high-barrier packaging ensures 24-month stability in Zone IVb tropical climates.
Thioguanine Tablets
FreeProduct Composition & Strength
We supply this product in the globally standardized 40 mg strength, optimized for adult and pediatric weight-based dosing.
Active Ingredient Strength Primary Clinical Function Thioguanine USP/Ph.Eur. 40 mg The DNA Saboteur: Mimics guanine to stop the replication of leukemic cells. Excipients Pharmaceutical Grade Stability Matrix: Engineered to protect the sensitive API from environmental degradation. Warfarin Tablets
FreeProduct Composition & Strengths
We supply this product in standardized, color-coded strengths to ensure precise dose titration, which is physically critical for this medication.
Active Ingredient Strength Primary Clinical Target Warfarin Sodium IP/BP/USP 1 mg Micro-Titration: For fine-tuned adjustments. Warfarin Sodium IP/BP/USP 2 mg Standard Maintenance: For stable anticoagulation. Warfarin Sodium IP/BP/USP 5 mg High Dose: For initial loading or resistant cases.
